drugset / Trial / NCT03261375
To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a prospective, multicenter, randomized sham-controlled trial to evaluate safety and efficacy of a multi-electrode radiofrequency renal denervation system (Netrod® System) in treating patients with uncontrolled essential hypertension.
Timeline
- Start
- 2021-01-19
- Primary completion
- 2022-12-26
- Completion
- 2022-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Hydrochlorothiazide | Unknown | — | — |
| Background | Nifedipine | Other / unclassified | — | — |